Isense Medical Corporation, AKA Metabolomx, focuses on disease diagnosis using metabolomics to directly analyze the activity of the metabolic pathways themselves by measurement of small molecule metabolites. Tumor metabolic pathways produce metabolites different than normal cells. These small molecule metabolites are volatile organic compounds (VOCs), they appear in alveolar blood, partition into the gas phase in exhaled breath producing a metabolic signature of disease in breath that can distinguished from that of healthy subjects. The company has developed technology enabling the identification of lung cancer and respiratory infection from breath.
